Oman MOH – Circular No. Circular No. 51/2026 – Suspension of Receiving Medicines and Biological Products Registration Files
OMAN MOH issued new Circular No. 51/2026 – Suspension of Receiving Medicines
OMAN MOH issued new Circular No. 51/2026 – Suspension of Receiving Medicines
NHRA has updated three key pharmaceutical regulatory guidelines in Bahrain as part
OMAN MOH issued new Circular No. 45/2026 – Adherence to Procuring Medicines
Qatar MoPH Issues Circular on Remaining Shelf Life Requirement for Imported Medicines
OMAN MOH issued new Circular No. 35/2026 introducing updated restrictions on the
SFDA issued the updated “Clinical Considerations for Vaccines” guideline – Version 2.0
The Saudi Food & Drug Authority (“SFDA”) has issued V 7.0 of
NHRA issues updated “Medicine Renewal Guideline” (Version 2.1) & “Medicine Variations Guideline”
SFDA Issues Final CMC Guidance for Human Gene Therapy Clinical Trial Applications.
SFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued